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Extended-spectrum beta-
lactamase-producing 
Klebsiella pneumoniae 
isolated from an abattoir 
worker in Cameroon
To the Editor: Extended-spectrum beta- 
lactamase (ESBL)-producing Enterobacteri-
aceae are a serious public health concern 
globally.[1] Beta-lactamases are chromosomal 
and plasmid-mediated enzymes that 
are able to inactivate beta-lactam anti-
biotics. They represent an important 
mechan ism of antibiotic resistance among 
Enterobacteriaceae such as Klebsiella 
pneumoniae.[2] The latter is among the 
foremost causative agents of both hospital- 
and community-acquired difficult-to-treat 
infections in humans, and has serious 
consequences.[1] However, the extent to 
which this bacterium could represent a 
public health threat through its spread from 
food animals such as pigs to humans has yet 
to be elucidated despite the well-established 
animal reservoir, emergence of resistant 
strains, and probable dissemination through 
the food chain.
During a multicentre study carried out 
from March to October 2016, nasal and 
rectal swabs were collected from 432  pigs 
in five abattoirs, three in Cameroon and 
two in South Africa (SA). Nasal and hand 
swabs were also collected from 82 humans 
in Cameroon (n=53) and SA (n=29). All 
samples were cultured overnight on 
MacConkey agar supplemented with 2 mg/L 
cefotaxime at 37°C, and putative ESBL 
producers were phenotypically confirmed 
via the Vitek 2 System and Vitek 2 Gram 
Negative Susceptibility card (AST-N255) 
(BioMérieux, France). The results were 
interpreted according to the Clinical and 
Laboratory Standards Institute (CLSI)[3] 
guideline, with the exception of colistin, 
amoxicillin + clavulanic acid, piperacillin/
tazobactam and amikacin, which were based 
on European Committee on Antimicrobial 
Susceptibility Testing (EUCAST)[4] break-
points. The genetic backbone of closely 
related isolates was molecularly characterised 
through whole-genome sequencing (WGS) 
on an Illumina MiSeq platform (Illumina 
Inc., USA) with 100× coverage. The bacterial 
analysis pipeline GoSeqIt tool (GoSeqIt, 
Denmark) was used to annotate and 
identify resistance genes, virulence factors 
and plasmids, respectively. The multi-locus 
sequence type was also determined through 
WGS.
One ESBL-producing K. pneumoniae, 
HH516E4IA (GenBank accession no. 
PCFF00000000), isolated from a hand swab 
of a slaughterer working in a pig abattoir in 
Yaoundé, Cameroon, displayed phenotypic 
resistance to several antibiotic classes 
(Table 1). This isolate was assigned to 
sequence type (ST) 39 with 100% identity 
among the seven housekeeping genes. In 
silico analysis using ResFinder with 90% 
identity as threshold corroborated the 
phenotypic resistance and revealed several 
genes encoding for resistance to beta-
lactams (blaCTX-M-15, blaSCO-1, blaSHV-11 and 
blaTEM-1B), aminoglycosides (aac(3)-IIa and 
aadA1), fluoroquinolones (oqxA and oqxB), 
fosfomycin (fosA), tetracyclines (tet(A)) 
and sulphonamides (sul1 and dfrA15) 
(Table 1). It additionally harboured one 
replicon (colRNAI) along with two plasmid 
incompatibility groups, namely IncFIB(K) 
and IncHI1B.
ESBL-producing K. pneumoniae ST39 
strains have been associated with severe 
outbreak situations and nosocomial 
infections worldwide, although there is 
limited information on their evolutionary 
emergence in the developing world. Our 
findings concur with a recent study which 
showed that ESBL-producing K. pneumoniae 
are actively disseminating in pigs and 
abattoir workers in Cameroon and are 
probably underestimated in the absence of 
molecular epidemiological studies. [2] The 
concomitant presence of genes encoding 
resistance to several antibiotic classes 
suggests that resistant commensal bacteria 
could contribute to the emergence/
dissemination of antibiotic resistance and 
represent a serious public health threat, as 
few therapeutic options remain available. 
The presence of IncFIB(K) and IncHI1B 
plasmid incompatibility groups highlights 
the horizontal transfer of resistance genes 
that may occur within and between 
commensal and pathogenic bacteria of the 
same species or genus. Detection of this ST 
has always prompted the implementation 
of stringent infection, prevention and 
control measures and ongoing surveillance 
of antibiotic resistance in hospital settings. 
Likewise, strict food safety measures should 
be implemented in the farm-to-plate 
continuum if we are to successfully contain 
the clonal spread of ESBL-producing K. 
pneumoniae in the food chain in developing 
countries, and especially in Cameroon.
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